Search results for "predictive"

showing 10 items of 1373 documents

The role of macrophage colony-stimulating factor in patients with acute myocardial infarction: a pilot study.

2011

We assessed whether macrophage colony-stimulating factor (M-CSF) levels are associated with left ventricular systolic dysfunction (LVSD) in patients with acute myocardial infarction (AMI). We studied 56 patients with AMI (mean age: 67 ± 12 years) and identified those with clinical (Killip class >II) or echocardiographic signs (ejection fraction ≤45%) of LVSD. We evaluated the established cardiovascular risk factors and measured several cardiovascular biomarkers, including M-CSF. Serum M-CSF concentrations (pg/mL) were significantly increased in patients with both clinical and echocardiographic signs of LVSD (460 ± 265 vs 290 ± 210, P = .0103 and 493 ± 299 vs 287 ± 174, P = .0028, respec…

Macrophage colony-stimulating factorMalemedicine.medical_specialtymacrophage colony-stimulating factor myocardial infarction heart failureMyocardial InfarctionPilot ProjectsLogistic regressionVentricular Dysfunction LeftPredictive Value of TestsInternal medicineMedicineHumansMyocardial infarctionKillip classAgedEjection fractionbusiness.industryMacrophage Colony-Stimulating FactorOdds ratiomedicine.diseaseConfidence intervalPredictive value of testsCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersAngiology
researchProduct

Overrating Classifier Performance in ROC Analysis in the Absence of a Test Set: Evidence from Simulation and Italian CARATkids Validation

2019

Background The use of receiver operating characteristic curves, or “ROC analysis,” has become quite common in biomedical research to support decisions. However, sensitivity, specificity, and misclassification rates are still often estimated using the training sample, overlooking the risk of overrating the test performance. Methods A simulation study was performed to highlight the inferential implications of splitting (or not) the dataset into training and test set. The normality assumption was made for the classifier given the disease status, and the Youden's criterion considered for the detection of the optimal cutoff. Then, an ROC analysis with sample split was applied to assess the disc…

Male020205 medical informaticsperformance estimatorsmedia_common.quotation_subjectHealth Informatics02 engineering and technology03 medical and health sciences0302 clinical medicineHealth Information ManagementSurveys and QuestionnairesStatisticstrue predictive performanceRinite Alérgica0202 electrical engineering electronic engineering information engineeringmedicineHumanssample splitComputer Simulation030212 general & internal medicineChildAsmaNormalityAsthmaMathematicsmedia_commonAdvanced and Specialized NursingReceiver operating characteristicasthma control testasthma control test sample split performance estimators optimal cutoff simulation study true predictive performanceDiscriminant validityReproducibility of ResultsEstimatormedicine.diseasesimulation studyRhinitis AllergicAsthmaConfidence intervalROC CurveTest setoptimal cutoffFemaleClassifier (UML)
researchProduct

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

2021

Background & Aims: The ANSWER study reported that long-term albumin administration in patients with cirrhosis and uncomplicated ascites improves survival. During treatment, serum albumin increased within a month and remained stable thereafter. In this post hoc analysis, we aimed to determine whether on-treatment serum albumin levels could guide therapy. Methods: Logistic regression was used to assess the association between baseline serum albumin and mortality, as well as to determine on-treatment factors associated with mortality and to predict the achievement of a given on-treatment serum albumin level. Survival was assessed by Kaplan-Meier estimates and second-order polynomial regres…

Male0301 basic medicineCirrhosisascites; complications; liver cirrhosis; serum albumin; survivalSerum albuminSurvival.Logistic regressionGastroenterologyBiomarkers PharmacologicalAscites; Cirrhosis; Complications; Serum albumin; Survivalascites0302 clinical medicineAscitesMedicinebiologyMiddle AgedIntention to Treat AnalysisTreatment OutcomeCirrhosisAsciteFemale030211 gastroenterology & hepatologyDrug Monitoringmedicine.symptommedicine.medical_specialtycomplicationsSettore MED/12 - GASTROENTEROLOGIAliver cirrhosisSerum albuminSerum Albumin Humansurvival03 medical and health sciencesSerum albumin levelPredictive Value of TestsInternal medicinePost-hoc analysisHumansIn patientBiological ProductsCirrhosiHepatologybusiness.industryAlbuminmedicine.diseaseLong-Term CareSurvival Analysis030104 developmental biologybiology.proteinbusinessComplication
researchProduct

Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the imme…

2018

Abstract Objective Previous studies on monitoring of post-transplant cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) are limited by single-centre designs and disparate risk categories. We aimed to assess the clinical value of a regular monitoring strategy in a large multicentre cohort of intermediate-risk kidney transplant (KT) recipients. Methods We recruited 124 CMV-seropositive KT recipients with no T-cell-depleting induction pre-emptively managed at four Spanish institutions. CMV-specific interferon-γ-producing CD4+ and CD8+ T cells were counted through the first post-transplant year by intracellular cytokine staining after stimulation with pp65 and immediate early-1 peptide…

Male0301 basic medicineMicrobiology (medical)medicine.medical_specialtyT-Lymphocytesmedicine.medical_treatment030106 microbiologyCongenital cytomegalovirus infectionCytomegalovirusAsymptomaticInterferon-gamma03 medical and health sciences0302 clinical medicineMonitoring ImmunologicPredictive Value of TestsRisk FactorsImmune monitoring intracellular cytokine stainingInternal medicinemedicineHumansCumulative incidenceLymphocyte Count030212 general & internal medicineKidney transplantationAgedImmunity Cellularbusiness.industryIncidence (epidemiology)virus diseasesImmunosuppressionGeneral MedicineMiddle Agedmedicine.diseaseKidney TransplantationTransplant RecipientsTransplantationInfectious DiseasesCytomegalovirus InfectionsCohortCell-mediated immunityFemalemedicine.symptombusinessClinical Microbiology and Infection
researchProduct

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort…

2021

BackgroundCheckpoint inhibitors revolutionized the treatment of metastatic melanoma patients. Although tumor burden and lactate dehydrogenase (LDH) are associated with overall survival (OS), the impact of tumor growth kinetics remains elusive and in part contradictory. The aims of this study were to develop a novel simple and rapid method that estimates pretreatment metastatic growth rate (MGR) and to investigate its prognostic impact in melanoma patients treated with antiprogrammed death receptor-1 (PD-1) antibodies.MethodsMGR was assessed in three independent cohorts of a total of 337 unselected consecutive metastasized stage IIIB–IV melanoma patients (discovery cohort: n=53, confirmation…

Male0301 basic medicineOncologyCancer ResearchSkin NeoplasmsTime Factors2437Programmed Cell Death 1 ReceptorPembrolizumabMetastasis0302 clinical medicineRisk FactorsImmunotherapy BiomarkersImmunology and Allergy1506Immune Checkpoint InhibitorsRC254-282MelanomaNeoplasms. Tumors. Oncology. Including cancer and carcinogensMiddle Agedddc:EuropeNivolumabTreatment OutcomeOncology030220 oncology & carcinogenesisCohortMolecular MedicineFemaleimmunotherapyNivolumabCohort studytumormedicine.medical_specialtyImmunologyAntibodies Monoclonal HumanizedRisk Assessment03 medical and health sciencesPredictive Value of TestsInternal medicinemelanomamedicineHumansCell ProliferationNeoplasm StagingRetrospective StudiesPharmacologyProportional hazards modelbusiness.industrybiomarkersReproducibility of Resultsmedicine.disease030104 developmental biologyTomography X-Ray ComputedbusinessBrain metastasis
researchProduct

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR…

2017

BACKGROUND: There is increasing evidence that metastatic colorectal cancer (mCRC) is a genetically heterogeneous disease and that tumours arising from different sides of the colon (left versus right) have different clinical outcomes. Furthermore, previous analyses comparing the activity of different classes of targeted agents in patients with KRAS wild-type (wt) or RAS wt mCRC suggest that primary tumour location (side), might be both prognostic and predictive for clinical outcome. METHODS: This retrospective analysis investigated the prognostic and predictive influence of the localization of the primary tumour in patients with unresectable RAS wt mCRC included in six randomized trials (CRY…

Male0301 basic medicineOncologyColorectal cancermedicine.medical_treatmentCetuximabmedicine.disease_causeEGFR Antibody0302 clinical medicineAntineoplastic Agents ImmunologicalNeoplasias ColorrectaisMedicineNeoplasm MetastasisRandomized Controlled Trials as Topicpredictive valuePanitumumabHazard ratiotumour sideAntibodies MonoclonalHematologyPrognosisChemotherapy regimenErbB ReceptorsBevacizumabTreatment OutcomeOncology030220 oncology & carcinogenesisFemaleKRASColorectal Neoplasmsmedicine.drugmedicine.medical_specialtyBevacizumabcolorectal cancerGenes ras03 medical and health sciencesAnticorpos MonoclonaisInternal medicineHumansChemotherapybusiness.industryAntineoplásicos ImunológicosOdds ratiomedicine.diseaserandomised trial030104 developmental biologyGenes rasHuman medicinebusinessprognosticanti-EGFR treatment
researchProduct

Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to devel…

2016

Disruption of the vectorial bile acid transport in the liver is a key feature of cholestatic drugs, although many causal and mechanistic aspects are still unknown. The aim of the present study was to explore if cholestatic drugs can repress or induce the expression of hepatic transporters. To this end, sandwich-cultured rat hepatocytes were treated with cholestatic and non-cholestatic (steatotic, non-hepatotoxic, etc.) drugs and the mRNA expression of 10 uptake and efflux biliary transporters was measured. Results evidenced that all cholestatic drugs cause extensive alterations in the mRNA expression of most biliary transporters. Surprisingly, nearly all steatotic drugs also affected the ex…

Male0301 basic medicinePathologymedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsDrug Evaluation PreclinicalOrganic Anion Transporters Sodium-IndependentPharmacologyBiologyToxicology030226 pharmacology & pharmacyRats Sprague-Dawley03 medical and health sciences0302 clinical medicineCholestasisPredictive Value of TestsIn vivomedicineAnimalsBileRNA MessengerCells CulturedCholestasisMultidrug resistance-associated protein 2Fatty liverTransporterGeneral Medicinemedicine.diseaseRatsFatty Liver030104 developmental biologyTetracyclinesHepatocytesBiomarker (medicine)EffluxSteatosisCarrier ProteinsBiomarkersToxicology Letters
researchProduct

Performance analysis of two immunochromatographic assays for the diagnosis of rotavirus infection

2017

Group A rotaviruses (RVAs) are the primary cause of acute gastroenteritis (AGE) in young children worldwide. Several commercial tests including latex agglutination, enzyme-linked assays (ELISA) and immunochromatographic tests (ICT) have been developed for the diagnosis of RVA infection. In the present study, the performance of two commercially available one-step chromatographic immunoassays, CerTest Rotavirus + Adenovirus (Biotec S.L, Zaragoza, Spain) and Vikia Rota-Adeno (bioMerieux SA, Lyon, France) were retrospectively evaluated using Real-time PCR as reference test. Re-testing by Real-time PCR of 2096 stool samples of children hospitalized with AGE previously screened by ICTs (1467 by C…

Male0301 basic medicineSettore MED/07 - Microbiologia E Microbiologia Clinica030106 microbiologymedicine.disease_causeSensitivity and SpecificityChromatography AffinityRotavirus InfectionsAstrovirusSentitivity03 medical and health sciencesPredictive Value of TestsVirologyRotavirusGenotypemedicineHumansImmunochromatographic AssaysDiagnostic ErrorsRetrospective Studiesbiologybusiness.industryInfant NewbornInfantRotavirubiology.organism_classificationVirologyGastroenteritisLatex fixation testRotavirus infectionItalyChild PreschoolSpecificityNorovirusFemaleImmunochromatographybusinessViral loadJournal of Virological Methods
researchProduct

Obesity and Abdominal Fat Markers in Patients with a History of Stroke and Transient Ischemic Attacks.

2016

Background Abdominal obesity is a well-recognized cardiovascular risk factor. Conflicting data concerning its significance with respect to stroke have been discussed in recent years. The objective of this study was to analyze the association between anthropometric parameters and the risk of stroke and transient ischemic attacks (TIAs) in German primary care. Methods Patient recruitment in this large-scale epidemiological study was performed in 3188 representative primary care offices in Germany. Among 6980 study participants, 1745 patients with a history of stroke or TIA were identified and matched for age and gender with 5235 regional controls. Associations between standard anthropometric …

Male030204 cardiovascular system & hematologyBody Mass Index0302 clinical medicineRisk FactorsGermanyEpidemiologyOdds Ratio030212 general & internal medicineStrokeAbdominal obesityAdiposityAged 80 and overAnthropometryRehabilitationMiddle AgedPrognosisStrokeIschemic Attack TransientArea Under CurveObesity AbdominalFemalemedicine.symptomWaist CircumferenceCardiology and Cardiovascular Medicinemedicine.medical_specialtyWaistAbdominal FatRisk Assessment03 medical and health sciencesPredictive Value of TestsInternal medicinemedicineHumanscardiovascular diseasesRisk factorAgedPrimary Health Carebusiness.industryWaist-Hip RatioOdds ratioAnthropometrymedicine.diseaseCross-Sectional StudiesLogistic ModelsROC CurveCase-Control StudiesPhysical therapySurgeryNeurology (clinical)businessBody mass indexJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct

Mid-regional pro-adrenomedullin predicts poor outcome in non-selected patients admitted to an intensive care unit.

2018

AbstractBackgroundMortality risk and outcome in critically ill patients can be predicted by scoring systems, such as APACHE and SAPS. The identification of prognostic biomarkers, simple to measure upon admission to an intensive care unit (ICU) is an open issue. The aim of this observational study was to assess the prognostic value of plasma mid-regional pro-adrenomedullin (MR-proADM) at ICU admission in non-selected patients in comparison to Acute Physiology and Chronic Health Evaluation II (APACHEII) and Simplified Acute Physiology Score II (SAPSII) scores.MethodsAPACHEII and SAPSII scores were calculated after 24 h from ICU admission. Plasma MR-proADM levels were measured by TRACE-Kryptor…

Male030213 general clinical medicinemedicine.medical_specialtyMultivariate analysisPrognosiMR-proADMClinical BiochemistrySAPSII030204 cardiovascular system & hematologylaw.invention03 medical and health sciencesAdrenomedullin0302 clinical medicinelawPredictive Value of TestsClinical endpointMedicineHumansMortalitySimplified Acute Physiology ScoreAgedAged 80 and overReceiver operating characteristicbusiness.industryBiochemistry (medical)Area under the curveGeneral MedicineOdds ratioMiddle AgedIntensive care unitConfidence intervalIntensive Care UnitsICUEmergency medicineMultivariate AnalysisFemaleAPACHEIIbusinessBiomarkersClinical chemistry and laboratory medicineReferences
researchProduct